EXOC8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.551600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.444600E-01
Normal-vs-Stage2
5.322800E-01
Normal-vs-Stage3
3.744800E-01
Normal-vs-Stage4
6.030200E-01
Stage1-vs-Stage2
4.851800E-01
Stage1-vs-Stage3
5.744100E-03
Stage1-vs-Stage4
2.183200E-01
Stage2-vs-Stage3
1.013610E-01
Stage2-vs-Stage4
5.482000E-02
Stage3-vs-Stage4
2.673700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.168600E-01
Normal-vs-AfricanAmerican
8.824400E-01
Normal-vs-Asian
5.972200E-01
Caucasian-vs-AfricanAmerican
2.165000E-01
Caucasian-vs-Asian
8.800200E-01
AfricanAmerican-vs-Asian
2.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.620400E-01
Normal-vs-Female
5.779600E-01
Male-vs-Female
8.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.177200E-01
Normal-vs-Age(41-60Yrs)
7.837400E-01
Normal-vs-Age(61-80Yrs)
5.119400E-01
Normal-vs-Age(81-100Yrs)
6.153200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.068400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.709400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.727600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.595180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.433030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.669400E-01
Normal-vs-Daily Drinker
2.109800E-01
Normal-vs-Weekly Drinker
6.611800E-01
Normal-vs-Occasional Drinker
9.321600E-01
Normal-vs-Social Drinker
6.834800E-01
Non Drinker-vs-Daily Drinker
2.539800E-01
Non Drinker-vs-Weekly Drinker
6.894800E-01
Non Drinker-vs-Occasional Drinker
3.244100E-02
Non Drinker-vs-Social Drinker
4.754400E-01
Daily Drinker-vs-Weekly Drinker
2.628800E-01
Daily Drinker-vs-Occasional Drinker
5.055400E-03
Daily Drinker-vs-Social Drinker
1.369750E-01
Weekly Drinker-vs-Occasional Drinker
2.620200E-01
Weekly Drinker-vs-Social Drinker
8.571800E-01
Occasional Drinker-vs-Social Drinker
2.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.774300E-02
Normal-vs-Grade 2
3.041700E-03
Normal-vs-Grade 3
7.895100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.483200E-01
Grade 1-vs-Grade 3
4.248200E-01
Grade 1-vs-Grade 4
3.774300E-02
Grade 2-vs-Grade 3
8.040800E-01
Grade 2-vs-Grade 4
3.041700E-03
Grade 3-vs-Grade 4
7.895100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.783600E-01
Normal-vs-NonDiabetic
5.295600E-01
Diabetic-vs-NonDiabetic
2.375000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.182000E-01
Normal-vs-NoPancreatitis
5.420800E-01
Pancreatitis-vs-NoPancreatitis
4.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.747200E-01
Normal-vs-N1
5.295000E-01
N0-vs-N1
4.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.090800E-01
Normal-vs-TP53-NonMutant
8.824800E-01
TP53-Mutant-vs-TP53-NonMutant
8.705000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
